Erik van Zandbergen

Erik van Zandbergen is currently the Chief Operating Officer at Julius Clinical, where he also holds the title of Chief Commercial Officer focusing on bold and creative drug development solutions. Additionally, he is the CEO of ENT Clinical, a company specializing in translational hearing discoveries into treatments for patients. Erik is the Company Owner of AvanZa Health and previously served as the VP Clinical Research at NIZO. With a background in project management and business development in the pharmaceutical industry, Erik has a strong track record of acquiring new clients and managing clinical trials. He holds a MSc in PharmD from the University of Groningen.